SLC2A1 and cancer: In glioma stem cells (GSCs), apigenin downregulated the expression of GLUT-1/3, NF-κB and PKM2 by inhibiting the expression of HIF-1α, inhibited the glycolysis process of cancer cells, and increased the radiosensitivity of GSCs (Zhao et al., 2021).